Efficacy of rilpivirine-based regimens as switch therapy from nevirapine-based regimens in HIV-infected patients with complete virological suppression: a randomised controlled trial

被引：0
|
作者：
Petchkum, P. [1 ]
Sungkanuparp, S. [2 ]
Kiertiburanakul, S. [1 ]
Phuphuakrat, A. [1 ]
机构：
[1] Ramathibodi Hosp, Div Infect Dis, Dept Med, Fac Med, Bangkok, Thailand
[2] Ramathibodi Hosp, Chakri Naruebodindra Med Inst, Fac Med, Samut Prakan, Thailand
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P107
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
    Weerawat Manosuthi
    Chatiya Athichathanabadi
    Sumonmal Uttayamakul
    Thanongsri Phoorisri
    Somnuek Sungkanuparph
    [J]. BMC Infectious Diseases, 7
  • [12] Switching from suppressive protease inhibitor-based regimens to nevirapine-based regimens: a meta-analysis of randomized controlled trials
    Ena, J.
    Leach, A.
    Nguyen, P.
    [J]. HIV MEDICINE, 2008, 9 (09) : 747 - 756
  • [13] Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin
    Manosuthi, Weerawat
    Sungkanuparph, Somnuek
    Thakkinstian, Ammarin
    Rattanasiri, Sasivimol
    Chaovavanich, Achara
    Prasithsirikul, Wisit
    Likanonsakul, Sirirat
    Ruxrungtham, Kiat
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (02) : 253 - 255
  • [14] Nevirapine-Based Regimens in Routine Clinical Settings: Results from a Large Italian Cohort of HIV-1 Infected Adults
    Rosso, Raffaella
    Rossotti, Roberto
    Di Biagio, Antonio
    Nicolini, Laura
    Adorni, Fulvio
    Orani, Anna
    Viscoli, Claudio
    [J]. CURRENT DRUG SAFETY, 2011, 6 (03) : 138 - 144
  • [15] Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapy
    Padmapriyadarsini, C.
    Ramesh, K.
    Sekar, L.
    Reddy, Devaraj
    Narendran, G.
    Sekar, S.
    Chandrasekar, C.
    Anbarasu, D.
    Wanke, Christine
    Swaminathan, Soumya
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 145 : 640 - 649
  • [16] Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy
    Arpadi, Stephen
    Shiau, Stephanie
    Strehlau, Renate
    Martens, Leigh
    Patel, Faeezah
    Coovadia, Ashraf
    Abrams, Elaine J.
    Kuhn, Louise
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2013, 98 (04) : 258 - 264
  • [17] Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults
    Fehintola, Fatai A.
    Scarsi, Kimberly K.
    Ma, Qing
    Parikh, Sunil
    Morse, Gene D.
    Taiwo, Babafemi
    Akinola, Ibrahim Tope
    Adewole, Isaac F.
    Lindegardh, Niklas
    Phakderaj, Aphiradee
    Ojengbede, Oladosu
    Murphy, Robert L.
    Akinyinka, Olusegun O.
    Aweeka, Francesca T.
    [J]. AIDS RESEARCH AND TREATMENT, 2012, 2012
  • [18] Renal safety of atazanavir-based regimens in HIV-infected patients
    Cure, S.
    Bianic, F.
    Espinas, C.
    Hardy, H.
    Rosenblatt, L.
    Juday, T.
    [J]. ANTIVIRAL THERAPY, 2013, 18 : A79 - A79
  • [19] Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients?
    Knobel, H
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (01) : 164 - 166
  • [20] Efficacy and safety of atazanavir- based regimens in routine management of HIV-infected adults
    Olczak, Anita
    [J]. HIV & AIDS REVIEW, 2009, 8 (01): : 9 - 11
12345